10x Genomics
- Market cap
- 9.92B
- P/E (TTM)i
- -128.98
- P/Bi
- 12.01
- EPSi
- -0.35
- Div yieldi
- 0.00%
- 52W posi
- 71%
Anonymous reader poll. Unscientific, not investment advice.
10x Genomics ended the session at 76.10, down 5.65%. That leaves the company valued at approximately 9.92B, the #1311 most valuable US-listed company we track. Across 11 analysts the consensus rating is Buy, with an average price target of 64.67 (-15%). The shares sit 71% of the way up their 52-week range of 11.16 to 102.81.
✦ StockVane Quant Insights how this is computed
- In the model portfolio — top-12 twelve-month momentum, trading above its 200-day average.
- Signal has read STRONG BUY for 3 weeks.
- Its last 4 Buy calls have actually lost 13% on average three months out - the strategy's edge here has come from the basket, not from this ticker.
- Recent price momentum is +328.6% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has risen to 12.8% of float.
- Analyst tilt is Buy.
- Price is below its 20-day average and above its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 80.66
- Open
- 77.52
- Day range
- 73.00 - 82.72
- Avg price
- 77.11
- Volume
- 9.38M
- Turnover
- 723.12M
- Turnover ratei
- 7.94%
- Volume ratioi
- 2.10
- Amplitudei
- 12.05%
- 52-week rangei
- 11.16 - 102.81
Valuation
- P/Ei
- -217.43
- P/E (TTM)i
- -128.98
- P/Bi
- 12.01
- EPSi
- -0.35
- Book value / shi
- 6.34
- Net profit
- -45.60M
- Net assets
- 825.52M
Share structure
- Market cap
- 9.92B
- Float capi
- 8.99B
- Shares out
- 130.29M
- Float sharesi
- 118.16M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 2019-09-12
26.0% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-13.74M net over the window
Short interest
- Shares short
- 16.69M
- % of floati
- 12.81%
- Days to coveri
- 7.09
- As of
- 2026-09-15
Frequently asked questions
What is the current stock price of 10x Genomics (TXG)?
10x Genomics last traded at 76.10. The quote on this page refreshes every few seconds while US markets are open.
What is 10x Genomics's market cap?
About 9.92B.
What is the P/E ratio of 10x Genomics?
The trailing twelve-month P/E is -128.98. The Valuation tab shows it against the stock's own five-year range.
Does 10x Genomics pay a dividend?
10x Genomics does not currently pay a regular dividend.
Is 10x Genomics a buy according to analysts?
The consensus of 11 analysts is a Buy rating, with an average 12-month price target of 64.67, which implies 15.0% downside from the current price. This is not investment advice.
What is 10x Genomics's StockVane Quant Rating?
The StockVane Momentum strategy currently rates 10x Genomics a A (Strong Buy). In the model portfolio — top-12 twelve-month momentum, trading above its 200-day average. Not investment advice.
Quote time 2026-10-08 06:39:55 · For reference only, not investment advice and not tailored to your situation.